JANUARY 13 TH, 2017 PARKVIEW MANOR, TORONTO, ONTARIO CONFERENCE CHAIRS Sunil Verma, MD, MSEd, FRCP Professor, University of Calgary Medical Director, Tom Baker Cancer Centre Christine Brezden-Masley, MD, PhD, FRCPC, MSc, BSc Medical Oncologist, Division Head of Hematology / Oncology Head of the Oncology Clinical Research Group, St. Michael s Hospital Assistant Professor, Dept. of Medicine, University of Toronto CHAIR OF THE PLANNING COMMITTEE Dr. Jean Maroun MD FRCPC FRCP(UK) Professor of Medicine, University of Ottawa Education Committee Member, Canadian Oncology Society RESERVE YOUR SPACE TODAY! PLEASE CONTACT: Lucas Severin, Event Coordinator lucas@oncologyeducation.com
Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 info@oncologyeducation.com October 28, 2016 Past Event Sponsors Alexion Pharmaceuticals Amgen Canada Inc Astellas Pharma AstraZeneca Canada Inc Bayer Inc Boehringer Ingelheim GmbH Bristol-Myers Squibb Canada Celgene Inc Eisai Limited Eli Lilly Canada Inc Genomic Health, Inc Gilead Sciences, Inc Janssen Inc Leo Pharma Inc Lundbeck Canada Inc Merck & Co., Inc Novartis AG Pfizer Canada Inc Dear Industry Partner, On behalf of the Organizing Committee (Dr. Sunil Verma, Dr. Christine Brezden-Masley and Dr. Jean Maroun) and OncologyEducation.com, we would like to invite you to join us as a sponsor for the annual Best of the San Antonio Breast Cancer Symposium at Parkview Manor on January 13, 2017. This meeting will serve to provide a summary of the most significant treatment advances presented at the Annual San Antonio Breast Cancer Symposium taking place from December 6th-10th, 2016. Presentations will be given by key opinion leaders and focus on the latest research with in-depth analysis and discussion to improve the current standard of breast cancer care. Meeting Objectives: Discuss pivotal trials and research presented presented at SABCS and apply them to the Canadian landscape; Review the current standard of care for key malignancies; Discuss the current controversies in the management of breast cancer. Benefit from numerous networking opportunities that allow you to meet face-to-face with oncology key opinion leaders and share updates on your latest products and service offerings. The Best of the San Antonio Breast Cancer Symposium audience and faculty will draw from among some of the most influential oncologists across Canada. Please note that all sponsorship amounts will need to include HST (HST #: 85627 3982 RT0001). All cheques should be made payable to CancerLink Ontario Inc. Payment should be sent by regular mail to Suite 378, 3219 Yonge Street, Toronto, ON, M4N 3S1, or we can arrange for direct deposit. Sponsorships are 100% due upon agreement in order to secure the spot. We value your partnership as a sponsor and we look forward to working with you. Don t hesitate to contact us if you have any questions. We look forward to seeing you in Toronto! Sincerely, Hoffmann-La Roche Ltd Sanofi Pasteur Limited Takeda Canada Inc Jason Hamburg, BSc., BEd. Managing Director Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 2 facebook.com/oncologyeducation info@oncologyeducation.com
MEET THE ORGANIZING COMMITTEE Sunil Verma, MD, MSEd, FRCP Professor, University of Calgary Medical Director, Tom Baker Cancer Centre Dr. Sunil Verma, MD, MSEd, FRCPC, is a Professor at the University of Calgary and Medical Director at the Tom Baker Cancer Centre. He completed his internal medicine and medical oncology training at the University of Alberta and then went on to a fellowship in breast cancer at the University of Toronto. He also completed his Master of Science in medical education from the University of California during his fellowship years. Dr. Verma s main clinical interests are in the treatment and management of breast cancer and lung cancer. He also has key research interests in neoadjuvant and endocrine treatment of breast cancer, reducing toxicity of systemic treatment, and developing novel therapies in breast and lung cancer. He has won numerous teaching awards and has also been recognized with many awards for his mentorship. Dr. Verma has led and created a number of national and international educational projects in oncology. He is well published, including being first author in New England Journal of Medicine along with other prestigious journals and is recognized internationally for his research and education leadership in breast and lung cancer. He is a member of several professional societies including ASCO, the Canadian Association of Medical Oncologists, and the Canadian Medical Association. Christine Brezden-Masley, MD, PhD, FRCPC, MSc, BSc Medical Oncologist, Division Head of Hematology / Oncology Head of the Oncology Clinical Research Group, St. Michael s Hospital Assistant Professor, Dept. of Medicine, University of Toronto Dr. Christine Brezden-Masley, MD, PhD, FRCPC, MSc, BSc, is a practicing Medical Oncologist and the Division Head of Hematology / Oncology at St. Michael s Hospital in Toronto and is the Head of the Oncology Clinical Research Group there. She obtained her PhD in Medical Biophysics at Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Assistant Professor at the University of Toronto. She is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto Region. She treats both Breast and GI (colorectal and gastric cancers) malignancies and these are the major areas of her clinical research. She Co-Chairs the annual Canadian Cardio- Oncology Network meeting focussing on cardiac health in cancer patients. She is active in research, education and has been instrumental in the clinical development of the cancer program at St. Michael s Hospital. Dr. Jean Maroun MD FRCPC FRCP(UK) Chair of the Planning Committee Professor of Medicine, University of Ottawa Education Committee Member, Canadian Oncology Society Dr. Maroun graduated from St. Joseph s University, Beirut, Lebanon. He completed his training in Internal Medicine in England where he obtained the M.R.C.P. (UK) in 1973. He specialized in Medical Oncology at the University of Ottawa and in the Department of Developmental Therapeutics at the M.D. Anderson Cancer Centre, Houston, Texas, USA. Dr. Maroun is a Professor of Medicine at the University of Ottawa and was nominated Fellow of the Royal College of Physicians of London, England in 1997. Until June 2002 Dr. Maroun was chair of Medical Oncology at the University of Ottawa and Head of Medical Oncology at the Ottawa Regional Cancer Centre and Ottawa Hospital. Dr. Maroun was chair of the Ontario Provincial Gastro-Intestinal Practice Guidelines Committee. He is a past President of the Canadian Oncology Societies and the Canadian Association of Medical Oncologists. Dr. Maroun has long experience in the management of GI malignancies and has been involved in clinical research into new drugs development and new combinations in the treatment of colorectal cancer. His clinical and basic research focus is on Thymidylate Synthase Inhibitors and other predictors for targeted therapy. Dr. Maroun has published extensively in peer reviewed journals and is involved provincially and nationally in numerous academic and research committees. twitter.com/onced linkedin.com/company/oncologyeducation-com 3
JANUARY 13 TH, 2017 PARKVIEW MANOR TORONTO, ON AGENDA 8:30 a.m. - 9:00 a.m. REGISTRATION, EXHIBITS, BUFFET BREAKFAST 9:00 a.m. - 9:15 a.m. Opening Remarks 9:15 a.m. - 9:45 a.m. Hormone Receptor Positive Breast Cancer 9:45 a.m. - 10:15 a.m. Her 2 Positive Breast Cancer 10:15 a.m. - 10:45a.m Neoadjuvant Treatment of Breast Cancer 10:45 a.m. - 11:00 a.m. Panel Discussion 11:00 a.m. - 11:15 a.m. BREAK 11:15 a.m. - 11:55 a.m. Breast Cancer Keynote Lecture 11:55 a.m. - 12:55 p.m. LUNCH + EXHIBITS 12:55 p.m - 1:25 p.m. Radiation Oncology Highlights 1:25 p.m. - 1:55 p.m. Surgical Oncology Highlights 1:55 p.m. - 2:25 p.m. Biology and Pathology Insights 2:25 p.m. - 2:40 p.m. Panel Discussion 2:40 p.m. - 2:55 p.m. BREAK 2:55 p.m. - 3:25 p.m. Triple Negative Breast Cancer 3:25 p.m. - 3:55 p.m. Novel Targets and Therapies in Breast Cancer 3:55 p.m. - 4:10 p.m. Panel Discussion 4:10 p.m. - 4:25 p.m. Summary and Concluding Remarks Visit: www.oncologyeducation.com/events
SPONSORSHIP LEVELS Sponsorship Entitlements Platinum ($17,500) Gold ($13,000) Bronze ($8,000) Acknowledgement of sponsorship level on conference Website Acknowledgement of sponsorship level on venue signage Acknowledgement of sponsorship level on all other documents 1 form of promotional material in delegate package 1 additional form of promotional material in delegate package 4 Complimentary full registrations 3 Complimentary full registrations 2 Complimentary full registrations Exhibit table (size to be confirmed by allowable venue space) Opportunity to sponsor breakfast or lunch symposium (or first refusal rights) Opportunity to have additional medical education booth + $4000 Additional Sponsor Badges Up to 2 additional badges may be purchased by any support level sponsor for $500/each. PLEASE NOTE: Non-supporting industry partners who wish to attend any of Oncology Education conferences will be charged a registration fee of $1500 per attendee. Please add 13% HST to ALL sponsorship payments. BREAKFAST/LUNCH SYMPOSIUM SPONSOR $25,000 INCLUDES: 4 Complimentary tickets for Symposia Naming right of the Symposia Sponsor Signage at symposia venue Marketing services/collateral development Project/registration management Archiving on OncologyEducation.com Audience response systems AV services Meals IF YOU WOULD LIKE TO SPONSOR OR HAVE ANY QUESTIONS PLEASE CONTACT: Lucas Severin, Event Coordinator lucas@oncologyeducation.com Please make all cheques payable to CancerLink Ontario Inc. Suite 378, 3219 Yonge Street Toronto, ON, Canada M4N 3S1 HST #: 85627 3982 RT0001 Suite 378, 3219 Yonge Street Toronto, ON, M4N 3S1 info@oncologyeducation.com facebook.com/oncologyeducation twitter.com/onced linkin.com/company/oncologyeducation-com
TERMS AND CONDITIONS 1. ALLOCATION OF EXHIBIT SPACE: OncologyEducation.com (OE) intends to allocate the selection of exhibit space for exhibitors booths on a first-come, first-served basis. OE reserves the right to make changes to the floor plan. 2. PAYMENT: Exhibitors shall make payments via check or credit card, payable in full to CancerLink Ontario Inc: Mail checks to: CancerLink Ontario, Inc. Suite 378, 3219 Yonge Street Toronto, ON, Canada M4N 3S1 Funds must be in CA dollars. Full payment must be received at time of application. 3. CANCELLATION OF CONTRACT: If cancellation is received by October 1st, 2016, a 50% refund will be credited. After that time, there shall be no refunds for cancellations. Exhibitor agrees that the total space rental fee for the cancelled space shall be retained or paid to OE. 4. ELIGIBLE EXHIBITS: OE reserves the right to determine eligibility of any company or product to participate in the exhibit. OE can refuse or revoke rental of exhibitor booth space to any company whose display of goods or services is not, in the opinion of OE, compatible with the character and objectives of the exhibit. In such event, this agreement shall terminate and OE shall refund all funds paid to it. 5. SUBLETTING OF EXHIBIT SPACE: Exhibitors may not assign, sublet, or share their exhibitor booth space to or with another business or firm. Should an article of a nonexhibiting firm be required for operation or demonstration in an exhibitor s display, identification of such article shall be limited to the usual and regular nameplates, imprint, or trademark under which same is sold in the general course of business. 6. AGREEMENT TO INDEMNIFY, HOLD HARMLESS, AND WAIVE: (a) Exhibitor agrees to make no claim of any nature whatsoever against OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors and assigns, or any of them, except for specified claims: (1) arising directly from the gross negligence of OE or its employees acting within the scope of their employment, and (2) caused by circumstances under the control of OE. This waiver shall include, without limitations: (i) loss, damage, or injury to any property of the exhibitor by fire, theft, destruction, vandalism, or any other cause, except that loss or damage directly attributable to the gross negligence of OE or its employees; (ii) any injury to the exhibitor, its agents, or employees by any cause, except for such injury directly attributable to the gross negligence of OE or its employees; (iii) loss, damage, or injury to the exhibitor s business by reason of space location or the failure to provide space for the exhibit, or by any failure to hold the exhibit as scheduled, and waiver as to such loss or injury shall here include claims arising from the gross negligence of OE, its employees or agents; (iv) loss, damage, or injury to the exhibitor s business caused by fire, electrical service interruption, or any other interruptive occurrence, and waiver as to such loss, damage, or injury shall here include claims arising from the gross negligence of OE, its employees, or agents; and (v) all consequential commercial damages arising out of any aspect of this agreement, including those damages resulting from the gross negligence of OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors, and assigns, or any of them. (b) The exhibitor shall indemnify and hold OE and its affiliates, their directors, officers, agents, servants, employees, subsidiaries, successors, and assigns, or any of them, harmless from and against any and all claims, penalties, damages, losses, costs, charges, and expenses whatsoever, including reasonable attorney s fees and costs arising out of the exhibitor s participation in the exhibit, except where such claims are directly attributable to the gross negligence of OE or its employees, including without limitation the following: (i) damage or injury to any person, persons, or property arising from or by reason of the occupation and use of the exhibit space; (ii) acts done or caused to be done by Exhibitor, its agents, employees, guests, or invitees; (iii) any breach by the exhibitor of its obligations hereunder; (iv) any loss, damage, or destruction to property of the exhibit facilities caused by the exhibitors, its agents, employees, guests, or invitees; and (v) any loss, theft, misappropriation or otherwise, or damage or destruction of any property of the exhibitor or its employees brought into the exhibit facility. (c) Exhibitor hereby agrees to waive the right of subrogation by its insurance carriers to recover losses sustained under its insurance contract for real and personal property, when permitted by its contracts with its carriers. The exhibitor understands that OE does not maintain insurance covering the exhibitor s property and it is the responsibility of the exhibitor to obtain such insurance. 7. BADGES: Badges will be required for entry into the exhibit hall at all times. Business cards are not to be used in exhibit badge holders. OE has the right to limit the total number of exhibitor credentials that may be included with each booth. 8. SECURITY: Exhibitors are responsible for the security of their exhibit. Exhibitors are solely responsible for securing all sensitive or valuable items. If insurance to cover the above is desired, it must be placed and paid for by the individual exhibitor. 9. ACCEPTANCE: This agreement shall be deemed accepted by OE when received by an authorized representative of OE, either in person or upon receipt by Mail or other delivery method and confirmed by OE with an Exhibitor Space Contract acceptance form specifying booth assignment. 10. OTHER REGULATIONS: Any and all matters not specifically covered by preceding rules and regulations shall be subject solely to the decision of show management. 11. ENTIRE AGREEMENT: The provisions contained herein constitute the entire agreement and supersede all previous communications, representations, and agreements either verbal or written, between the parties hereto with respect to the subject matter hereof. *Sponsorship information may be changed by OncologyEducation.com without prior notice and the new rates will apply only to sponsors who have not yet committed to support for the event.